ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Dr. Paul Gagne Launches Vascular Care Connecticut to Deliver Patient-Centered Care to Darien

September 20, 2021 GMT

DARIEN, Conn.--(BUSINESS WIRE)--Sep 20, 2021--

Vascular Care Connecticut, a state-of-the art private practice committed to the prevention, diagnosis and treatment of vascular disease, announced today the opening of a new center located in Darien, Conn. Paul J. Gagne MD, FACS, RVT, a board-certified vascular surgeon, distinguished fellow of the Society of Vascular Surgery, and former director of the Vascular Research Laboratory at New York University’s Hospitals Center, will serve as the center’s founder and lead physician. He brings over two decades of surgical experience, including over ten years in private practice in Darien.

ADVERTISEMENT

“By augmenting the local hospital systems with specialized outpatient care, vascular centers such as ours can play a vital role in optimizing patient care locally,” said Dr. Gagne. “Outpatient vascular centers offer a highly personalized experience that puts the patient at the center of the care model and can save payers from unnecessary expenses. We’re pleased to offer experienced, personalized patient care to Fairfield County.”

Dr. Gagne specializes in vascular and endovascular techniques for the treatment of arterial and venous disease. He has a specific focus on the endovascular repair of abdominal aortic aneurysms, treatment of carotid artery and venous disease, including varicose veins, acute deep vein thrombosis (DVT), chronic deep vein disease (post DVT), venous ulcers, and lower extremity peripheral artery disease.

“Every element of our new center was built with the patient experience in mind,” said Dr. Gagne. “We have found we can dramatically improve the patient experience and positively impact patient outcomes by bringing high-level care to patients in the communities where they live. Our center is built to deliver state-of-the art, minimally invasive care where and when patients need it the most.”

ADVERTISEMENT

Vascular Care Connecticut is dedicated to being on the cutting edge of innovation and new technologies for vascular disease and providing patients the care they need in a convenient and uncomplicated environment. In addition to his record of superb patient care, Dr. Gagne has been an influential innovator and leader in the vascular care community and is a world-renowned subject matter expert in deep vein care. Clinical trials are ongoing at Vascular Care Connecticut. Further, Dr. Gagne was the global principal investigator for The Venogram vs IVUS for Diagnosing Iliac vein Obstruction trial (VIDIO), which was published in The Journal of Vascular Surgery, and is the principal investigator in several ongoing, multi-center clinical trials. He has been named an Associate Clinical Professor of Surgery at NYU School of Medicine. Prior to joining the Vascular surgery faculty at NYU, Dr. Gagne served in the U.S. Navy as both a general and vascular surgeon.

To learn more about Vascular Care Connecticut, please visit vascularct.com.

About Vascular Care Connecticut

Vascular Care Connecticut is committed to the prevention, diagnosis, and treatment of vascular disease. Our Board-certified vascular specialists and expert clinical team are dedicated to compliance and training in the latest methods for maximizing safety and effectiveness. Vascular Care Connecticut brings together decades of experience to offer unparalleled care in Connecticut.

View source version on businesswire.com:https://www.businesswire.com/news/home/20210920005107/en/

CONTACT: Press and Media Inquiries:

Matter Communications

Deanna Meservey

dmeservey@matternow.com

KEYWORD: UNITED STATES NORTH AMERICA CONNECTICUT

INDUSTRY KEYWORD: MANAGED CARE GENERAL HEALTH HEALTH SURGERY

SOURCE: Vascular Care Connecticut

Copyright Business Wire 2021.

PUB: 09/20/2021 08:30 AM/DISC: 09/20/2021 08:32 AM

http://www.businesswire.com/news/home/20210920005107/en